Dr. Sattar received ASTM International’s Award of Merit

The 2017 Award of Merit was granted to Dr. Sattar on April 04 at a special ceremony in Toronto following the semi-annual meeting of ASTM International’s Committee E35 on Pesticides, Antimicrobials and Alternative Control Agents of which he has been an active member since 1993. Seven test methods developed by him are now standards of ASTM and are referenced globally to assess disinfectants and antiseptics for their activities against human and animal pathogens. ASTM International (formerly known as the American Society for Testing and Materials) is a highly prestigious standards-setting organization with nearly 32,000 members worldwide. Its Award of Merit was established in 1949 by ASTM International’s Board of Directors and is the highest society award granted to an individual member for distinguished service and outstanding participation in ASTM International committee activities. Recipients also receive the honorary title of Fellow. The Award was presented to Dr. Sattar by Mr. Thomas Marsh, Chairman of ASTM International’s Board of Directors. The citation read was as follows: In recognition of and gratitude for your many years of dedication to ground-breaking research in environmental microbiology and commitment to ASTM International’s Committee E35 on Pesticides, Antimicrobials and Alternative Control Agents in the form of authored standards and generous mentoring of E35.15 members.

Scientists at CREM Co Labs developed Tier 3 of quantitative carrier test (QCT-3)

Scientists at CREM Co Labs have recently developed a quantitative method to assess the decontamination of high-touch environmental surfaces (HITES) by wiping in a field-relevant manner. The method is suitable for work with all major classes of human pathogens as well as common types of environmental surfaces. It can also assess the transfer of pathogen contamination to clean surfaces during wiping. This method, named Tier 3 of quantitative carrier test (QCT-3), builds on the two tiers (QCT-1 and QCT-2) we had developed earlier.


CREM Co's scientists published the first peer-reviewed test of decontamination devices for car interiors. In the study, the investigators “salvaged parts from a four door sedan and reassembled them in our laboratory to recreate the passenger cabin,” said Sattar, who is also Chief Scientific Officer, CREM Co. Labs, Mississauga, Ontario, Canada. The mock-up was housed within a biosafety level 2 containment facility, to guard against the escape of pathogens used in the testing.

Jean-Yves Maillard Joined CREM Co's advisory board

CREM Co is pleased to announce the addition of Dr. Jean-Yves Maillard to our Advisory Board. Dr. Maillard, Professor of Pharmaceutical Microbiology, Cardiff University, Cardiff, Wales, is a world-renowned researcher in infection prevention and control. He has an extensive list of publications to his credit in addition to having received numerous prestigious awards for his scientific achievements. Further details on his illustrious career can be found at

Translation of Dr. Sattar's article in Farsi

Since 2019-nCoV spread in Iran and Middle East, Dr. Sattar's article "HUMAN PATHOGENIC CORONAVIRUSES: UNDERSTANDING THEIR ENVIRONMENTAL SURVIVAL FOR BETTER INFECTION PREVENTION AND CONTROL" was translated to Farsi. ویروس کرونا: درک بهتر از بقای ویروس کرونا در محیط جهت پیشگیری و کنترل بیماری عفونی ناشی از آن


COVID-19 will most certainly not be the last such virus to confront humanity. In fact, many on-going climatic and societal changes are poised to favour the emergence of viruses and other human pathogens. In the meanwhile, we are learning crucial lessons every time a new pathogen emerges. For example, the SARS and MERS viruses have taught us better ways to counter COVID-19. Finally, we must revive the practice of IPAC as generic and effective approaches to counter existing and emerging pathogens while efforts are underway to develop safer and effective vaccines and drug.

Volunteers  Needed for Testing Handrubs

Volunteers are needed to participate in an approved study to test how well handwash and handrub agents can get rid of disease-causing germs on human hands. If you are: • 18 to 65 years old • in good general health • not pregnant • not taking antibiotics or on hormone therapy Should you agree to participate, you will receive in person a detailed explanation of the objectives of the study and the test procedure involved. You will then have time to review the information before deciding to sign an informed consent form. If selected, you will be required either for three 90-minute visits or three four-hour visits at the laboratory for the testing. You will also receive, free-of-charge, a set of microbicide-free personal care products (e.g., soap and shampoo) for use during the study starting one week before your first test. You will be free to stop your participation in the study anytime you chose to do so. Just before each test, your hands will be inspected thoroughly to make sure that the skin is free of any cuts or damage. In case of any such damage, you will not be allowed to take part in the testing till your hands have healed completely. For the testing, you will wash your hands and forearms with soap and water and rub some alcohol over them. Then, a small quantity of a virus or bacterium (totally safe for the skin) will be placed on each fingerpad or forearm for treatment with the test handwash or handrub agent. You will then wash and dry your hands/forearms well before leaving the laboratory. The testing will not cause you any pain or discomfort. You will also not be identified in any reports or publication arising from the study. For visits lasting about 90 minutes, you will receive $25.00/visit (total of $75.00) to cover any out-of-pocket expenses. If you are required to participate in tests lasting four hours, the compensation/visit will be $100.00 (total of $300.00). A cash payment will be made after your participation in the study is complete.